Co-Founder/Director/CEO
Awen Oncology
The startup specializes in pre-clinical oncology drug development, utilizing structural biology and in-silico drug candidate screening to identify new therapeutic targets for malignancies. This approach enables rapid and efficient development of effective treatments, addressing the urgent need for innovative cancer therapies in the healthcare sector.
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- The startup specializes in pre-clinical oncology drug development, utilizing structural biology and in-silico drug candidate screening to identify new therapeutic targets for malignancies. This approach enables rapid and efficient development of effective treatments, addressing the urgent need for innovative cancer therapies in the healthcare sector.